Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Thymoma and thymic carcinoma
Stage/Subtype:  thymic carcinoma
Country:  U.S.A.
Trial Type:  Treatment
Results 1-3 of 3 for your search:
Start Over
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CDKO-125a-006, NCI-2014-02427, 2009-014338-79, NCT01011439
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CDKO-125a-007, NCI-2014-02428, NCT01301391
Targeted Enzyme Inhibitor Therapy in Treating Patients with Advanced Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Thymic Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0096, NCI-2013-01478, 110096, P10782, 8639, NCT01306045
Start Over